Scandoil  

Siemens becomes a strategic automation partner for GlaxoSmithKline


Published Sep 9, 2015
Siemens Energy-2

Siemens and GlaxoSmithKline have entered a global strategic partnership. Siemens will become a strategic partner of GSK in manufacturing automation and thus the preferred automation supplier for GSK production and R&D sites worldwide, including Vaccines.

This new agreement further develops the long standing successful relationship between both companies and helps GSK to refresh their global automation strategy.

Dave Tudor, Vice President Primary Supply and leader of the Global Automation Steering Team of GSK, said: “I am delighted we have reached agreement to make Siemens a strategic partner. One of our objectives is to simplify and standardize the automation space by identifying a small number of systems and suppliers and this is the first step on our journey to achieving this. This will create a real win-win situation, not just for today, but for the long term, for GSK, Siemens and most importantly our patients.

Tags: Siemens




Advertisment:

Add a Comment to this Article

Please be civil. Job and promotion will not be added into the comment page.

(Use Markdown for formatting.)

This question helps prevent spam:

+ Larger Font | + Smaller Font
Top Stories

 

 

 

 


 


RSS

RSS
Newsletter
Newsletter
Mobile News
Mobile news

Computer
Our news on
your website


Facebook
Facebook
Twitter
Twitter

Contact
Contact
Tips
Do you have any
tips to us
Stats

 

sitemap xml